NCT04190004View on ClinicalTrials.gov

Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Schizophrenia
Interventions
DRUG

Vasopressins

40 International units of vasopressin or placebo will be given intra-nasally. The order of the administration will be counterbalanced

DRUG

Placebo

40 International units of vasopressin or placebo will be given intra-nasally. The order of the administration will be counterbalanced

Trial Locations (1)

560029

National Institute of Mental Health and Neurosciecnes, Bangalore

All Listed Sponsors
lead

National Institute of Mental Health and Neuro Sciences, India

OTHER

NCT04190004 - Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia | Biotech Hunter | Biotech Hunter